Transapient Musings of an S6 Archailect
Hey there, my name is Bryan Bishop. Here's to trying to keep up with yourself. RSS.
   

About
Transapient Musings of an S6 Archailect

Metacognitive trivialities over smooth topologies and Julian knots of subgeometric spaces; a.k.a mastermind Singularitarian, node of the Larger Submind and Clone of the Ineffable Original.

Bryan Bishop
http://heybryan.org/
email: kanzure@gmail.com
AIM: kanzure
ICQ: kanzure
YIM: kanzure
Skype: kanzure
Jabber/G-talk: kanzure@gmail.com
MSNM: cm007x2@yahoo.com
IRC: irc.freenode.net (#hplusroadmap)
phone: #1-512-203-0507


Archives

       

Wed, 11 Jun 2008

What's mine is mine: Brain scans reveal what's behind the aversion to loss of possessions
src

Did you ever wonder why it is so difficult to part with your stuff? A new study reveals fascinating insights into the specific neuropsychological mechanisms that are linked with the potential loss of possessions. The research, published by Cell Press in the June 12 issue of the journal Neuron, has important implications for both neuroscience and economics and may even explain why you are reluctant to sell your iPod.

posted at: 12:00 | path: /sci/bio/neuro | permanent link to this entry

Which Cognitive Enhancers Really Work: Brain Training, Drugs, Vitamins, Meditation or Exercise?
src


Can 'brain training' software really increase useful, everyday cognitive function?
Although wisdom may come with age, our brains don't get any faster. Many areas of cognitive function decline over time: attention wavers, processing speed decreases, memory starts to crumble.

All kinds of methods for fighting back against this brain-wide slow-down have been suggested. There is training with computer programs, popping pills, taking nutritional supplements, meditating or even getting some more exercise.

Some want to ward off the scourge of a rapidly ageing population: dementia. Others are looking for competitive advantage against younger, faster brains.

So: what to choose? These methods, along with many others, are often presented as though they're all roughly equivalent, but this isn't true. The scientific evidence currently available is much stronger for some of these options than others.

This post examines what the research currently tells us about each method for cognitive enhancement and delivers a verdict on each.

1. Brain training

Computer programs that promise to improve cognitive function have become all the rage in recent years, mostly on the back of the success of Nintendo's 'Brain Age' game. Many other companies have now jumped on the bandwagon and the market for brain fitness software reached $225 million in the US in 2007 according to a report from SharpBrains.

But what about the science behind the hype?

Certainly cognitive training has been shown to be effective in a few randomised controlled trials, but the evidence is still quite limited. The first large study in older adults without dementia failed to find an improvement in daily functioning from the training, but it did slow decline. Also, this study's method has been criticised.

Other studies have found benefits for specific groups such as children with attention deficit hyperactivity disorder (ADHD) and dyslexia. Whether advantages gained by these groups might be effective for others is a matter for debate.

The real challenge for brain training is showing that practising one type of mental skill transfers over into other real-life benefits. Doing puzzles like Sudoku or completing crosswords probably only improves your performance on those specific tasks.

One new study, though, does suggest that training working memory can increase fluid intelligence - what we use to solve problems which don't rely on things we already know. The study, recently published in The Proceedings of the National Academy of Sciences, found that gains in fluid intelligence were proportional to the amount of working memory training completed.

Unfortunately this is still early-stage exploratory research and many are not convinced that the actual products available on the market are beneficial. Sandra Aamodt, the editor in chief of Nature Neuroscience and Sam Wang, a Princeton University molecular biologist explain in the New York Times:
"In the United States, consumers are expected to spend $80 million this year on brain exercise products, up from $2 million in 2005. Advertising for these products often emphasizes the claim that they are designed by scientists or based on scientific research. To be charitable, we might call them inspired by science -- not to be confused with actually proven by science."

It's telling that the best-selling brain training software - Nintendo's 'Brain Age' - has the lowest level of clinical validation according to a market report from Sharp Brains.

Verdict: Evidence for the benefits of cognitive training for everyday functioning is still very limited. Brain training software currently available is mostly 'inspired by science' rather than based on it. Treat marketers' claims with extreme scepticism. Side-effects are probably limited to repetitive strain injury and a depleted wallet.

2. Drugs

Until recently the main chemical cognitive enhancer most people used was caffeine. But there are a whole batch of new drugs that could challenge caffeine's dominance as the safe stimulant of choice. Of these, two well-known for their 'off-label' use are Modafinil (also known as Provigil) and Ritalin.

Modafinil was originally developed to treat narcolepsy, but is now used by many people as a cognitive enhancer. Studies reported by the Academy of Medical Sciences have shown that Provigil does indeed improve aspects of memory: mainly verbal working memory, planning performance, working memory and executive inhibitory control (ability to stay on-task).

Other important aspects of cognitive function such as attention, however, were not affected by Modafinil. This study found Modafinil did not enhance spatial memory span, rapid visual information processing or attentional set-shifting. This study also found that Modafinil did not enhance attention.

The reason many use Modafinil is that it doesn't seem to have any short- or long-term side-effects and it is not addictive (although it's lack of side-effects may well have been exaggerated). For example it doesn't increase blood-pressure or heart-rate, as caffeine does. It may give you a headache, though, just like caffeine.

Ritalin was originally developed to treat ADHD yet adults have begun using it as a cognitive enhancer. It seems to work best in young people, enhancing spatial working memory and cognitive flexibility. Effects on other aspects of cognition such as verbal learning and long-term memory are relatively small.

In most people Ritalin tends to improve mood, increase activity and arousal, but it's effects are more varied and can include anxiety, tiredness and lowered mood.

Verdict: Amongst the chemical cognitive enhancers Modafinil is currently fashionable for grown-ups. But is it really that much better than caffeine? This study and this study suggest that in warding off sleep Modafinil is no more effective than caffeine - and caffeine is legal and readily available. Probably better to stick to tea or coffee.

3. Nutritional supplements

There are all kinds of claims for the abilities of nutritional supplements to enhance cognition. For example, vitamin B6 has been found to enhance memory (but far from conclusively) and there are many other claims being made by marketers for vitamins E, B12, folate, neurosteroids and so on.

However, in reviewing the research the Academy of Medical Sciences points out that most of the studies are few, far between and small in scope.

Verdict: Unproven, but probably not dangerous as long as you're not exceeding the recommended daily allowances. On the downside supplements can be costly.

4. Meditation

Meditation, like nutritional supplements, is another modern cure-all, but what does the evidence tell us about its effect on cognitive function? A forthcoming review of the research published in the Annals of the New York Academy of Sciences looks at the effects of meditation on cognitive function.

There is some limited evidence that meditation can benefit cognitive function overall, and memory in particular. But this research is at a very early stage and needs to be replicated by different researchers.

A major problem in this research is the fact that there are many different types of meditation. It might be that there is some kind of common active ingredient in meditation, but this has yet to be identified.

Verdict: Meditation still has to be considered unproven as a cognitive enhancer but it probably won't do you any harm, plus it's free.

5. Exercise

Whether you're old or young, fit or even suffering from a neurodegenerative disorder, aerobic exercise has been found to be beneficial for cognitive health. Randomised controlled trials, along with reviews of many of these trials (such as this one in Neuromolecular Medicine), have shown that exercise improves cognitive function across the board. It has also been found to be particularly good at enhancing executive control processes (e.g. planning and working memory).

Exercise is also thought to encourage the growth of new brain cells. In the past scientists always thought that neurogenesis - growing new brain cells - was impossible in humans. New studies, though, have shown that we can grow new brain cells.

Research reviewed in Neuromolecular Medicine suggests physical exercise can promote neurogenesis in the hippocampus - an area of the brain thought to be important in memory and learning.

Verdict: The evidence for exercise boosting cognitive function is head-and-shoulders above that for brain training, drugs, nutritional supplements and meditation. Scientifically, on the current evidence, exercise is the best way to enhance your cognitive function. And as for its side-effects: yes there is the chance of an injury but exercise can also reduce weight, lower the chance of dementia, improve mood and lead to a longer life-span. Damn those side-effects!

The results are in (for now)

Even though exercise is the current winner for enhancing cognition, this might change in the future. Maybe better drugs for enhancing brain function will be developed - possibly en route to improved treatments for conditions like Alzheimer's. Or maybe studies on nutritional supplements, brain training software or particular forms of meditation may provide firmer evidence.

Maybe.

On current evidence exercise is clearly the best method for increasing useful everyday cognitive functioning. And in the future we may even have exercise regimes that are specifically targeted at enhancing cognitive function.



posted at: 11:58 | path: /sci/bio/neuro | permanent link to this entry

Open Source Drug Discovery gets Funding
src

Mat Todd reports on the Synaptic Leap:

We've been successful in securing a large government grant with an open source component. The 3-year project concerns the enantioselective synthesis of PZQ for a low price, with the World Health Organisation as partner. (PDF of the Uni Sydney outcomes is here). The funding comes from the Australian Research Council (the main government funding agency in Australia). We wrote the proposal emphasising the possibilities inherent in the open source approach to doing science, and we're very pleased that this was seen as positive by an official grant-funding agency. The funding will allow us to increase our efforts on using TSL to drive our project forward much faster.


posted at: 11:57 | path: /sci/bio/drugs | permanent link to this entry

The hidden universal distribution of amino acids biosynthetic networks: a genomic perspective on its origins and evolution
src

Background:
Twenty amino acids are the universal building blocks of proteins. However, their biosynthetic routes do not appear to be universal from an Escherichia coli-centric perspective. Nevertheless it is necessary to understand their origin and evolution in a global context - i.e. to include more 'model' species and alternative routes-. We use a comparative genomics approach to assess the origin and evolution of amino acid biosynthetic alternative network branches.
Results:
We predicted a core of widely distributed network branches biosynthesizing at least 16 out of the 20 standard amino acids, suggesting that this core occurred in the last common ancestor by tracking the taxonomic distribution of amino acids biosynthetic enzymes. Additionally, we detail the distribution of two types of alternative branches to this core: i) analogs - enzymes that catalyze the same reaction (using the same metabolites) and belong to different superfamilies; and ii) 'alternologs' - herein defined as branches that, proceeding via different metabolites converge to the same end product-. We suggest that the origin of alternative branches is closely related to different environmental metabolite sources and life-styles among species.
Conclusions:
The multi-organismal seed strategy employed in this work improves the precision of dating and evolutionary relationships among amino acids biosynthetic branches. This strategy could be extended to diverse metabolic routes and even other biological processes. Additionally, we introduce the concept of 'alternolog', which not only plays an important role in the relationships between structure and function in biological networks, but also as shown here, has strong implications on their evolution, almost equal to paralogy and analogy.

posted at: 11:54 | path: /sci/bio | permanent link to this entry

Body position affects memory for events
src

This article was originally posted on March 27, 2007

ResearchBlogging.orgdijkstra1.jpgWhen we see a familiar face, or even a photo of a favorite car or pet, we're often flooded with memories from our past. Sometimes just seeing a person or object that's similar to the ones in our memory will trigger recollections we never knew we had. Maybe you've had a memory triggered by a scent or the texture of an object. Sometimes emotions such as happiness or anger will spur vivid memories, too.

A new study adds an unexpected method to the list of ways to spur memories about our past: body position. That's right: just holding your body in the right position means you'll have faster, more accurate access to certain memories. If you stand as if holding a golf club, you're quicker to remember an event that happened while you were golfing than if you position your body in a non-golfing pose.

Even more fascinating than the facts about body position and memory is how they were learned. A team led by Katinka Dijkstra actually had young adult and older adult volunteers assume different body positions while asking them to remember particular events from their lives. Sometimes the body position matched the memory:

Read the rest of this post... | Read the comments on this post...

posted at: 11:44 | path: /sci/bio/neuro | permanent link to this entry

In which I get funded: The Comparative Biogerontology Initiative
src


I’m on a team that just got awarded a Keck Futures Initiative grant. This is the fruit of the NAKFI conference we attended last year on “The Future of Human Healthspan.” It was an unusual conference: instead of giving individual talks, the participants were split up into “task groups” that were each assigned a different question related to the biology of aging. At the end of the conference, each group gave a presentation. (The proceedings are available in overpriced booklet form here or as free HTML here).

Our group started off with one subject (stochasticity of gene expression) but took a sharp left turn and ended up thinking more broadly. We ended up focusing on what evolutionary biology might teach us about aging.

Within groups of species that share a given body plan (e.g., bats, birds, dogs, or primates), there is significant variation in maximum life expectancy, and we believe this variation is genetically determined. In other words, natural selection has performed dozens of parallel “experiments” in which more or less similarly constructed organisms end up with different lifespans, based on variations in a range of factors (some known or long-suspected, like antioxidant enzymes, and others as yet undetermined). Some of these factors may be unique to specific body plans, whereas others might be universal. The challenge we set ourselves was ambitious: How can we use the “data set” (i.e., variation in lifespan among related organisms) to identify novel determinants of longevity? Thus was born the Comparative Biogerontology Initiative.

We soon realized that we’d need a great deal of expertise, not only from within biogerontology but also from other fields, some with which we often have dealings (biostatistics, computational biology) and others with which we have almost no interaction in our daily professional lives (veterinary medicine, pathology, histology, comparative physiology). Identifying the relevant experts is a profound challenge in itself: How does one identify expertise in a field in which one has none? Hence a lot of what we’re going to be doing at first is figuring out who our collaborators will be — leading to the contorted mission statement:

These researchers will hold two meetings with senior scholars to develop a plan to test hypotheses about biological factors that control lifespan and healthspan, and compare tissues from multiple species of animals. The scholars are pathologists, comparative physiologists, methodologists, statisticians, and experts in the biology of aging.

“Hold…meetings…to develop a plan to test hypotheses”…no doubt, this will inflame the sensibilities of those who advocate a more direct frontal assault on the problem of aging; indeed, if this were all we were planning to do, they would have a point. We know a lot about aging and it makes sense to move forward aggressively where knowledge is already extensive — but those efforts are being undertaken already, and will continue. All of us are keeping our day jobs.

The CBI was conceived not as a replacement for more direct studies of more relevant models (like humans), but as a complement: by carefully examining aging in understudied organisms, and by systematically identifying the factors that contribute to their differential longevities, our hope is to discover entirely new determinants of aging and lifespan. By bringing in expertise from around the scientific world, including disciplines that don’t usually overlap with biogerontology, our hope is to break new ground in the biology of lifespan (and, if you like, to open new fronts in the battle against aging). In the process, we’ll learn more about the evolutionarily conserved bases of aging throughout the animal kingdom, identify new biomarkers of aging, and pose enough new questions to keep the next generation of biogerontologists busy for years to come.

The other members of the team are, dare I say it, eminences grises of biogerontology — some of whose work and thoughts (e.g., Steve Austad and Richard Miller) we’ve discussed here in the past (and one of whom is my current boss, Judy Campisi). I’m personally thrilled for a chance to work with and learn from them.

And who knows? After we hold our meetings to develop a plan to test a hypothesis, we might actually test one, and then I can blog about it here. Watch this space for further developments.



posted at: 11:44 | path: /sci/bio | permanent link to this entry

The meaning response
src

I am currently reading Daniel Moerman's "Meaning, medicine and the 'placebo effect'". As well as containing many interesting asides, the book discusses what is at the heart of the so-called placebo effect: patients' response to the meaning of their treatment. Moerman calls this the 'meaning response'. This response to meaning explains why two inert pills produce more cures than one inert pill, and why inert injections are even more effective (because "everybody knows" that injections are more powerful than pills). But importantly, it is possible to show that doctors are as important in producing the meaning response as patients. Gracely et al (1985) looked at the effect of placebo on pain in patients having their wisdom teeth extracted. The study was set up as a standard double-blind (neither the doctor nor the patient knows if the patient is getting a real medicine or an inert placebo), with the possibilities being a placebo, fentanyl (which usually reduces pain) and naloxone (which usually blocks reduction in pain, so could be expected to increase the pain of the procedure). The twist was that for the first half of the experiment the doctors, but not the patients, were told that a supply problem meant that no patient would be getting the pain-relieving fentanyl. In the second half the doctors were told that the problem had been resolved, so that now the patients might receive fentanyl. By comparing levels of patient pain in the placebo condition is possible to gauge the effect of doctor expectations on the meaning response of the patients. In this condition patients are all receiving inert substances, and they all 'know' the same thing: they might receive a placebo, pain-relief or 'pain-enhancement'. The doctors don't tell them about the supply problem and, for that matter, they don't know themselves for definite what the patient is given. The only difference is that for the patients in the first half, the doctors think they know that pain-relief is not a possibility, whereas in the second half it is. The graph of the results, copied from Moerman's book is below:

placebo.png

As you can see, patients in the PN group --- those whose doctors thought they might receive pain-relief had a large pain-relieving placebo effect. Those in the PNF group --- those whose doctors thought they couldn't receive pain-relief --- didn't have a pain-relieving placebo effect.

What I think is interesting about this study is, firstly, it confirms the need for rigorous double-blind controls in studies of medicine and, secondly, just how significant an effect this subtle manipulation has. The doctors don't know anything definite, and they certainly aren't telling the patients what they suspect or guess, but somehow --- a look? a slightly brighter smile? a slightly lowered tone? --- they communicate their knowledge of the probabilities to the patients who then experience a real change in their levels of pain because of it.

A striking aspect of the meaning response is that one could suppose that patients have control over their experience of different levels of pain. After all, we know that the pills are inert. Could we just imagine ourselves a 'placebo effect' in all situations where we have unnecessary pain? Sadly, normally we can't do this --- the meaning response doesn't work like that. Doctors are required to give patients permission to feel less pain. Perhaps a fundamental part of the creation of meaning is that it requires other people.

Update: A great recent post by Vaughan 'placebo is not what you think', which deserves to be linked up with this post

Refs

Gracely, R. H., Dubner, R., Deeter, W. R., & Wolskee, P. J. (1985). Clinicians' expectations influence placebo analgesia. Lancet, 1(8419), 43.

Moerman, D. E. (2002). Meaning, medicine, and the "placebo effect". Cambridge University Press: New York.



posted at: 11:42 | path: /sci/bio | permanent link to this entry

Electrically controlled microvalves to integrate microchip polymerase chain reaction and capillary electrophoresis
src

Govind V. Kaigala, Viet N. Hoang, Christopher J. Backhouse
(Paper from Lab Chip)
Govind V. Kaigala, Lab Chip, 2008, DOI: 10.1039/b802853b
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry

posted at: 11:41 | path: /sci/bio | permanent link to this entry

Carbon nanotube field effect transistors for the fast and selective detection of human immunoglobulin G
src

Cristina C. Cid, Jordi Riu, Alicia Maroto, F. Xavier Rius
(Communication from Analyst)
Cristina C. Cid, Analyst, 2008, DOI: 10.1039/b805301b
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry

posted at: 11:40 | path: /sci/bio | permanent link to this entry

Artificial organelles: nanotechnology beyond simple drug delivery
src

The same nanotech approaches being explored to deliver drugs exactly to the cells where they are needed also provide a technology base that might lead to permanent enhancements of human metabolism. Excerpts from “Cell ‘organs’ get plastic upgrades“, by Tamsin Osborne at NewScientist.com news service:

Human cells could have their metabolisms upgraded without altering their genes by inserting tiny plastic packages of enzymes, Swiss researchers have shown. They hope the technique could allow advanced cancer therapies, or even upgrade a person’s metabolism.

The cells of multi-cellular organisms and some advanced single-celled organisms have internal compartments called organelles to carry out specialised metabolic functions. Researchers at University of Basel, Switzerland, used artificial polymer organelles to upgrade live human cells in a lab dish.

Meier and colleagues coated their polymer vesicles in a chemical that encouraged human white blood cells called macrophages to engulf them. The small capsules contained enzymes, just like natural organelles. The enzymes chosen produced fluorescent chemicals, signalling they were working without problems inside their new host.

The artificial organelle’s membrane can be chemically tuned to control which chemicals can pass through it and regulate the reactions inside, according to Wolfgang Meier, one of the researchers. “We call it a ‘nanoreactor’,” he says.

At 200 nanometres across, the organelles are 400 times smaller in width than a human hair.

Meier says the artificial organelles would also work in other human cells, opening up the possibility of a new cancer therapy that tricks diseased cells into poisoning themselves from the inside out…

Although the immediate interest is in drug delivery, the researchers involved are mindful that more sophisticated artificial organelles could provide metabolic services beyond the natural human repertoire.

Artificial organelles might also be able to treat conditions caused by a deficit of a particular enzyme. For example, someone with lactose intolerance could have their digestive cells given artificial organelles containing lactose-digesting enzymes.

In the far future, it might be possible to introduce non-human metabolic functions into human cells. “We could, in principle, bring in a nanoreactor that [lets] your skin do something like photosynthesis. So if you are hungry, you just lie in the Sun,” says Meier.

The research was published in Nano Letters (abstract).
—Jim



posted at: 11:39 | path: /sci/bio | permanent link to this entry

What's more convincing than talking about brains? Pictures of brains!
src

ResearchBlogging.orgNot long ago we discussed work led by Deena Skolnick Weisberg showing that most people are more impressed by neuroscience explanations of psychological phenomena than plain-old psychology explanations. Talking about brains, it seems, is more convincing than simply talking about behavior, even when the neuroscience explanation doesn't actually add any substantive details.

Now David McCabe and Alan Castel have taken this work on the acceptance of neuroscience to a new level: now they've got pictures! They asked 156 students at Colorado State University to read three different newspaper articles about brain imaging studies. The articles were completely fake, and they all discussed brain imaging, but one of the articles included only text, one included a bar graph showing brain-scan results, and one showed pictures of brains. The articles were about three different topics, but an equal number of students saw each article with text only, the graph, or the brain image.

For example, in one of the fake studies, the claim was made that TV-watching is related to math ability. As evidence, students read a text explanation, or saw one of these two figures:

mccabe1.gif

The [fake] claim was that since the same area of the brain is activated while doing arithmetic or watching TV, that the two activities are related. The students then rated this article for whether its scientific reading made sense, on a scale of 1 (strongly disagree) to 4 (strongly agree). Here are the results:

Read the rest of this post... | Read the comments on this post...

posted at: 11:34 | path: /sci/bio/neuro | permanent link to this entry

Origin of Life, Now in Video Form
src

Janet Iwasa has had an unusual scientific career. After finishing her PhD with Dyche Mullins at UCSF she started a postdoc in Jack Szostak’s lab at Harvard but not to do bench work or even simulations like her postdoc colleagues. Instead, Janet is a full time animator and graphic designer. She takes the current work done in the lab and translates the experimental results and speculated mechanisms into beautiful animations. For more on her story, check out this post at Nature Network.

One of the results of her efforts is a recently completed web site on the origin(s) of life called Exploring Origins. It’s full of striking images and animations that depict RNA enzymes folding into their active structures, the dynamics of lipids in micelles and vesicles, and also more speculative processes like how micelles could have formed around an ancient geyser. And best of all, she’s used a creative commons license so her work is available for educational use including in presentations. If your interests overlap at all with hers then your future audiences are in for a treat because these videos can be used to quickly and entertainingly get across complex ideas.

Of course, this is just one of Iwasa’s projects and you can find more examples of her work on her website. I especially like the illustration of clathrin-mediated endocytosis.



Szostak has been increasingly showing up in my searches through the literature.

posted at: 11:27 | path: /sci/bio | permanent link to this entry

Oh, great. Now we know what the right parahippocampal gyrus does.
src



Or so declares an article in the New York Times:

The Science of Sarcasm (Not That You Care)

By DAN HURLEY
Published: June 3, 2008


There was nothing very interesting in Katherine P. Rankin’s study of sarcasm — at least, nothing worth your important time. All she did was use an M.R.I. to find the place in the brain where the ability to detect sarcasm resides. But then, you probably already knew it was in the right parahippocampal gyrus.
But of course. Other bloggers have already posted about this story (so go on, read more about sarcasm, social cognition and theory of mind there). The original research findings have yet to appear as a full-length publication, but Rankin and her colleagues presented this work at the recent American Academy of Neurology meeting in Chicago.

The NYT article continues:

Although people with mild Alzheimer’s disease perceived the sarcasm as well as anyone, it went over the heads of many of those with semantic dementia, a progressive brain disease in which people forget words and their meanings.

“You would think that because they lose language, they would pay close attention to the paralinguistic elements of the communication,” Dr. Rankin said.

To her surprise, though, the magnetic resonance scans revealed that the part of the brain lost among those who failed to perceive sarcasm was not in the left hemisphere of the brain, which specializes in language and social interactions, but in a part of the right hemisphere previously identified as important only to detecting contextual background changes in visual tests.

“The right parahippocampal gyrus must be involved in detecting more than just visual context — it perceives social context as well,” Dr. Rankin said.

It's not as simple as all that, Rankin et al. note in their own abstract. Worse performance in the Sarcasm test was also associated with greater atrophy in other sectors of the right temporal lobe and in the right superior frontal gyrus. Moreover, a 2005 study [BBC link via Of Two Minds] implicated a network of brain regions, primarily right ventromedial prefrontal cortex [they could not assess the importance of the right temporal lobe in their study]:
Dr Simone Shamay-Tsoory and colleagues (Neuropsychology, 2005) studied 25 people with prefrontal lobe damage, 16 with damage to the posterior lobe of the brain and 17 healthy volunteers.

. . .

The volunteers who had damage to their prefrontal lobes were unable to correctly interpret the sarcastic story, while all of the other participants could...

[Dr Shamay-Tsoory] said language areas on the left hand side of the brain interpret the literal meaning of words and the frontal lobes and the right side of the brain understand the social and emotional context.

An area called the right ventromedial prefrontal cortex then integrates the literal meaning with the social/emotional context, which will reveal any sarcasm.

"A lesion in each region in the network can impair sarcasm, because if someone has a problem understanding a social situation, he or she may fail to understand the literal language," she said.
Oh well, "whatever", nevermind. I couldn't get The Sarcasterizer to work, so there you go.
It's "certain" that nobody's gotten tired of the insincerity and detached irony that's so prevalent in today's "hip" discourse. There's nothing the the world quite as "thrilling" as stumbling across yet another Web page drenched in "disaffected" sarcasm. And "everybody's" constantly asking us where they can get "more" of this "precious" commodity.
UPDATE: bigger better multiple sarcasms.


References

[IN2-2.004] Detecting "Sarcasm" from Paralinguistic "Cues": Anatomic and Cognitive "Correlates" in Neurodegenerative Disease

Katherine Rankin, Andrea G. Salazar, Maria Gorno Tempini, Danijela Pavlic, Christine M. Stanley, Shenly Glenn, Michael Weiner, Bruce Miller.

OBJECTIVE: To investigate the structural neuroanatomy underlying neurodegenerative disease patients failure to understand sarcasm from dynamic vocal and facial paralinguistic cues. BACKGROUND: While sarcasm can be conveyed solely through contextual cues such as counterfactual or echoic statements, face-to-face sarcastic speech may be characterized by a specific paralinguistic profile that alerts the listener to interpret the utterance as ironic or critical, even in the absence of contextual information. DESIGN/METHODS: Ninety-one subjects (20 frontotemporal dementia, 11 semantic dementia [SemD], 4 progressive nonfluent aphasia, 28 Alzheimer's, 6 corticobasal degeneration, 9 progressive supranuclear palsy, 13 healthy older controls) were tested using the Social Inference-Minimal subtest of The Awareness of Social Inference Test (TASIT). Subjects watched brief videos depicting sincere or sarcastic communication and answered yes-no questions about the speakers intended meaning. RESULTS: All groups performed normally interpreting items on a Sincere control task, suggesting other cognitive impairments did not significantly account for Sarcasm task performance. Only the SemD group was impaired on the Simple Sarcasm condition. Subjects failing the sarcasm comprehension task performed more poorly on dynamic emotion recognition tasks, had more neuropsychiatric disturbances, but had better verbal and visuospatial working memory than patients who comprehended sarcasm. Voxel-based morphometry analysis of TASIT scores was performed using age, sex, total intracranial volume, and performance on the Sincere condition as covariates. Poorer sarcasm recognition correlated with right temporal lobe atrophy (anterior fusiform and parahippocampal gyrii, superior temporal sulcus), and atrophy to the right superior frontal gyrus and striatal structures (right caudate and left globus pallidus) (p less than 0.05, FWE). CONCLUSIONS/RELEVANCE: This study provides lesion data suggesting that the right posterior temporal lobe and dorsomedial frontal cortex are associated with recognizing and interpreting sarcastic irony using paralinguistic vocal and facial cues, consistent with functional imaging research examining neural correlates of voice prosody, facial emotion recognition, and perspective taking.

Shamay-Tsoory SG, Tomer R, Aharon-Peretz J. (2005). The neuroanatomical basis of "understanding" sarcasm and its "relationship" to social cognition. Neuropsychology 19:288-300.




posted at: 11:22 | path: /sci/bio/neuro | permanent link to this entry

Microsurgery on the brain of the fruit fly leads to new insights into irreparable nerve injuries
src

Leuven, Belgium − Every year, one million Europeans are confronted with potentially irreparable brain or spinal cord injuries resulting from traffic accidents. Because the nerves in a damaged spinal cord cannot, or cannot fully, be repaired, the patient remains (partially) paralyzed. Now, VIB scientists connected to the K.U.Leuven have become the first to successfully develop a simple model that enables the study of injured brain tissue. The researchers have perfected a technique for keeping the cultured brain of a fruit fly alive and healthy for a longer period of time. With the aid of microsurgery, this new technique enables scientists to inflict injury on certain nerve bundles for research purposes. By means of this new fruit fly model, the researchers have already succeeded in showing that the activation of a particular signaling pathway (JNK) induces the regeneration of axons. This research offers positive perspectives for patients with nerve injuries that have been irreversible up to now.

read more



posted at: 11:18 | path: /sci/bio/neuro | permanent link to this entry

Wonders of extraction: Water
src


Extraction of peppermint leaves with hot water

Water is a polar molecule, meaning that one end has a small negative charge and the other a small positive charge. Because of this water is a very good solvent for other polar molecules and ions. For instance water is the solvent of choice for substances that provide taste, be it salt, sour, sweet or bitter as these are normally quite polar molecules.

A general rule is that the solubility of molecules and ions increases with the temperature of the water. Extractions are therefore faster if the water is boiling. This is the reason why we use hot water to extract tea leaves or ground coffee beans, even if we want to prepare ice tea or ice coffee. But by lowering the temperature and extending the extraction time we can change the relative proportion of what we extract. It therefore makes perfectly sense that different temperatures are recommended for different types of tea. Using different temperatures for the same kind of tea will of course also influence the flavor profile.

Polar molecules are more easily extracted than non-polar molecules. This is evident if we leave a tea bag for a long time in hot water. The bitter taste is due to the slow extraction of large polyphenol molecules which are less soluble in water. If tea is brewed at a lower temperature, less of the bitter tasting substances will be extracted.

Although water is polar, less polar and even non-polar substances can be extracted with water, especially if the water is boiling hot. You do this every day when prepare coffee. If you take a close look at cup of freshly brewed coffee you can notice small pools of oily substances floating on top of the coffee. The more severe conditions used when extracting coffee to make an espresso ensure that even more oily substances are extracted. Other examples of extraction using water in the kitchen include preparation of stock, soups and gravies.

The principle of extraction is simple, but a number of questions remain largely unexplored with regard to flavor: How do ions affect extraction? What role does pH play? How does temperature influence flavor? There is surprisingly little research on this that includes a sensory evalution.



posted at: 11:16 | path: /sci/bio | permanent link to this entry

Update on GIFT cancer treatment
src

Knowledge of Health provides a review of cancer treatment that is leading up to human clinical trial in the summer 2008 where cancer-killing granulocytes obtained from humans who exhibit high immunity against cancer will be injected into cancer patients. The review is selective and the author believes that vitamin D would also help with some cancer treatment.

This is an update to a prior report on the "GIFT" cancer treatment and cancer resistant mice.


Dr Cui took blood samples from 100 volunteers, and mixed just their granulocytes with cervical cancer cells in the laboratory. He found that one sample appeared to kill 97% of the cancer cells in just two days, while at the other end of the scale, after 48 hours, one sample had destroyed just 2% of the cancer cells.



[from wikipedia] Granulocytes are a category of white blood cells characterised by the presence of granules in their cytoplasm. They are also called polymorphonuclear leukocytes (PMN or PML) because of the varying shapes of the nucleus, which is usually lobed into three segments. In common parlance, the term polymorphonuclear leukocyte often refers specifically to neutrophil granulocytes, the most abundant of the granulocytes.


Online search of Wake forest cancer clinical trials

Online search of all cancer related clinical trials in the United States

FURTHER READING
Zheng Cui, MD PhD webpage at Wake Forest University

The granulocyte therapy work is described at the Wake Forest pages.

Wake Forest Cancer center

Clinical trials at Wake Forest in general



posted at: 11:16 | path: /sci/bio | permanent link to this entry

A survivor in Greenland: A novel bacterial species is found trapped in 120,000-year-old ice
src

A team of Penn State scientists has discovered a new ultra-small species of bacteria that has survived for more than 120,000 years within the ice of a Greenland glacier at a depth of nearly two miles. The microorganism's ability to persist in this low-temperature, high-pressure, reduced-oxygen, and nutrient-poor habitat makes it particularly useful for studying how life, in general, can survive in a variety of extreme environments on Earth and possibly elsewhere in the solar system. The work will be presented by Jennifer Loveland-Curtze, a senior research associate in the laboratory led by Jean Brenchley, Professor of Biochemistry and Molecular Biology at Penn State, at the 108th American Society for Microbiology General Meeting in Boston, Massachusetts on 3 June 2008 at 10:30 a.m. (Extreme Environments-I, poster N-156).

read more



posted at: 11:14 | path: /sci/bio | permanent link to this entry

The most accurate infographic ever & the brain region responsible for sarcasm
src

steve_icon_medium.jpg This is actually pretty much the most useful and accurate infographic I've ever seen in my entire life. Thank goodness this appears on an article highlighting the brain region responsible for decoding sarcasm.

_41176509_sarcasm_416.gif

Now that you've seen this amazing infographic you know exactly how sarcasm happens in the brain and what area is responsible.... AND!!! that area is lighting up right now as you read this very deep and meaningful post. As a matter of fact after reading this post you might have an aneurysm originating in your right ventromedial prefrontal gyrus. I apologize for the brain deadness I might have caused from reading this post. However, it's not as bad as it could be... just read the bbc news article that the infographic came from ;)

I haven't had a chance to read the real journal article yet... maybe I'll do that and get back to you guys.

HT: Eamon

Read the comments on this post...

posted at: 11:12 | path: /sci/bio/neuro | permanent link to this entry

Oops
src

We recently encountered a problem that’s (unfortunately) a rather common one. An enzyme assay turned up an interesting hit compound, with some characteristics that we were hoping to see for leads against our target. A re-test showed that yes, the activity appeared to be real, which was interesting, since this hit was a welcome surprise from a class of compounds that we weren’t expecting much from.

It was a comparatively old compound in the files, and all we could find out was that it had been purchased rather than made in house. Looking around, it seemed that there were very few literature references to things of this type, and only one commercial source: the Sigma-Aldrich Library of Rare chemicals, known as SALOR. That, though, was a potential warning flag.

Those compounds come from an effort started by Aldrich’s Alfred Bader many years ago, who started trolling around various academic labs looking for unusual compounds that no one wanted to keep around any more. Over time the company has accumulated a horde of oddities that are often found nowhere else, but there are several catches. For one, these things are usually available only in small quantities, tens of milligrams for the most part. That’s plenty for the screening files, but you’re not going to make a bunch of analogs starting from what comes out of a SALOR vial. Another catch is that the compounds are sold, very explicitly, as is: the university sources tell Aldrich what’s on the label, so that’s what they sell you and caveat emptor all the way, dude.

So often as not, you get what we got, a nice-looking white powder which, on closer analysis, turned out to only have a vague relationship to the structure on its label. We knew that we were in trouble as soon as the first NMR came out: way too much stuff in one region, nowhere near enough in some others. Mass spec confirmed that this thing weighed more than twice as much as what it was supposed to. We’ve since pretty much nailed down what the stuff really is, and our interest in it has decreased as each of the veils has been removed from the real structure.

We’re correcting the data in our own screening files, of course. And yes, we’re going to tell the folks at Aldrich to change their label, too, assuming they have any of this stuff left. At least the next person will know what they’re getting. For once. But there are more of these things waiting out there – in every large compound collection, in every catalog, in every collection of data are mistakes. Watch for them.



posted at: 11:11 | path: /sci/bio | permanent link to this entry

What the tip of the tongue tells us about the brain
src

The tip-of-the-tongue state is a common experience where you know you know something but can't quite bring it to mind. This everyday experience has told us a great deal about how the mind and brain work, as explored in an article for the Boston Globe.

It's a paradoxical experience if you think about it. You know something, but you can't remember it.

Just this tells us that the storage of information and the ability to access it are distinct in the brain.

It also tells us that the brain must have ways of monitoring itself and communicating how successfully it carries out its operations to the conscious and unconscious mind.

This is known as 'metacognition' and is one of the most important concepts in modern psychology.

The Boston Globe article (by Jonah Lehrer of the Frontal Cortex blog) is a remarkably lucid exploration of exactly this topic, looking at how it has been studied in everything from lab studies to people with brain injury who suffer near permanent tip-of-the-tongue states.


Link to Boston Globe article 'What's that name?'.



posted at: 11:02 | path: /sci/bio/neuro | permanent link to this entry